Moreover, we also identified a significantly higher number of AURKB and TβRI complexes in sections from patients with aggressive prostate cancer compared to those from patients with less aggressive disease; in normal prostate tissues almost no signals were observed (Figure 5b and S4e). Here, TGFBR1 is linked to prostate cancer.